- GROUP Survivorship
- PROJECT SPAN 2024
- DATE 01/01/2024
Background
A plenary on financial toxicity at the 2020 COSA ASM catalysed the establishment of the Financial Toxicity Working Group as a sub-group of the COSA Survivorship Group. Working Group members represent a broad range of expertise from around Australia, and includes consumers and Cancer Council representation. Find out more about the Working Group's activities below.
Details on this project
Raymond Chan |
|
|
Megan Varlow |
Financial toxicity is:
"The negative patient-level impact of the cost of cancer. It is the combined impact of direct out-of-pocket costs and indirect costs and the changing financial circumstances of an individual and their household due to cancer, its diagnosis, treatment, survivorship and palliation, causing both physical and psychological harms, affecting decisions which can lead to suboptimal cancer outcomes."
Read COSA's Financial Toxicity in Cancer Care Definition Statement
The Roadmap to Reducing Financial Toxicity Experienced by People Affected by Cancer aims to identify and implement initiatives across the cancer care ecosystem that reduce, and ultimately eliminate, financial stress from decisions regarding access to optimal treatment and care.
The need for a comprehensive and collaborative approach to reducing financial toxicity in cancer care was a key outcome of the Working Group's National Think Tank on Financial Toxicity in Cancer Care.
COSA has previously endorsed the Standard for Informed Financial Consent as a key component of delivering quality care (developed by Breast Cancer Network Australia, Cancer Council Australia, Canteen and Prostate Cancer Foundation of Australia).
Financial Toxicity survey of Australian Health Professionals
Our Working Group conducted a national survey to understand how healthcare professionals perceive and approach financial toxicity. Two papers on this work have now been published:
Financial toxicity papers by COSA Members
Cancer Survivors' Experience of Care and Financial Toxicity: Results From a National Survey
Measures of financial toxicity in cancer survivors: a systematic review
Exploring the role of general practitioners in addressing financial toxicity in cancer patients
Juggling cancer and life in Survivorship: the role of general practitioners
Screening for financial toxicity in clinical care with finance-related outcome measures
Financial Navigation in Australia Live Webinar (28 July 2025)
Financial Toxicity Research in Australia Live Webinar (25 May 2025)
Prof Raymond Chan: ways of addressing financial toxicity (recorded by the limbic at the 2023 COSA ASM)
Five steps out of financial toxicity (published by Oncology Republic following the 2023 COSA ASM)
Cancer's unspoken financial burden (2023 COSA ASM media release)
COSA leads the charge against financial toxicity (2023 COSA ASM Daily Digest)
"Where was I going to find this money? - Cancer's unseen side effect" (from the UNSW newsroom)
Collaborative webinar: Challenging the misconception that nothing can be done to address financial toxicity.
- For cancer information and support contact Cancer Council’s Information and Support Line on 13 11 20
- For financial, legal or workplace resources visit https://www.cancercouncil.com.au/cancer-information/legal-work-and-financial-issues/
- Cancer Council Financial cost of cancer policy
Related projects
Survivorship
Patient Reported Outcomes (PRO) Working Group
Survivorship
Survivorship Group Collaborative Webinar Series
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 5 days ago
Our Cancer Pharmacists Group Clinical Development Workshop is back! This 3-hour educational afternoon will take place on Tuesday 11 November at the Adelaide Convention Centre. COSA CPG members and other interested pharmacists are encouraged to attend.
Read More >
COSAoncology 6 days ago
Save the date for the PGX Debate! COSA, @CAPhO_ACPhO @ISOPPorg and @BOPACommittee leaders will face off in a lively 3-minute-thesis-style debate - Is pharmacogenomics over-rated? - Evidence, energy and humour guaranteed! Tuesday 28 October 8:00PM AEDT
Read More >
COSAoncology 13 days ago
It is just six weeks till the multidisciplinary cancer care community meets in Adelaide for #COSAIPOS2025 to share insights, highlight innovation and influence best practice. View the packed program
Read More >
COSAoncology 20 days ago
Catch the Highlights of ISOPP CAPhO Symposium 2025 in a live webinar Saturday 27 September 7:30am AEST. Speakers include @DrKEWatson, Melanie Danilak & Prof Lita Chew. The webinar is free for members of @COSAoncology @ISOPPorg @CAPhO_ACPhO @BOPACommittee.
Read More >
COSAoncology 20 days ago
Our September member newsletter is out now. Check your inbox for COSA news – opportunities, group and affiliate updates, webinars, journal articles and more. Or log in and read it online anytime at
Read More >
COSAoncology 22 days ago
Check your inbox for the September Nutrition Group eNews for journal articles, PD, resources and more. If you're not subscribed, login to your COSA member account
Read More >
COSAoncology 27 days ago
@COSAoncology @ASCO @EuropeanCancer are using their collective voices to raise awareness of challenges impacting the wellbeing of health professionals and to define principles for creating healthy workplace cultures in health systems. See Lancet Oncology
Read More >
COSAoncology 28 days ago
Exercise & Cancer / Global Oncology Group Fellowship opportunities! COSA is offering two Fellowships to early-mid career researchers to coordinate and lead a study to develop a model of care for exercise oncology for a lower-middle-income country setting.
Read More >
COSAoncology 29 days ago
The latest Survivorship eNews is out now! With working group updates, new COSA-endorsed resources, journal articles, COSA-IPOS 2025 key survivorship sessions & more. Check your inbox, visit
Read More >
COSAoncology 29 days ago
Cancer Pharmacists Group Fellowship opportunity! COSA is offering an early career researcher mentorship, guidance and support to develop a COSA position statement on 'Documentation of Hypersensitivity Reactions to SACT'. Find out more
Read More >